大细胞肺癌
- 化疗
-
- 抗代谢类
- Pemetrexed
- Gemcitabine
-
- 拓扑异构酶抑制剂
- Etoposide
- 免疫检查点抑制剂
-
- PD-1
- Pembrolizumab
- Nivolumab
-
- PD-L1
- Durvalumab
- 相关化合物库
- FDA-approved Anticancer Drug Library
- Anti-cancer Compound Library
- Anti-cancer Compound Library-Ⅱ
- Anti-cancer Metabolism Compound Library
- Cambridge Cancer Compound Library
- FDA-approved Drug Library
- 靶向疗法
-
- ERK
- Bortezomib
-
- IGF-1R
- Picropodophyllin
-
- MAPK
- Metformin
-
- STAT
- Fludarabine
-
- ALK
- Crizotinib
-
- VEGF
- Bevacizumab
